Funding stagnation for biomedical sciences in the United States is sending European researchers back to Europe, says this Nature news article. The prospects there are rosier, especially in Britain's cancer centers, where funding has risen by 51 percent to $799 million since 2002 while the US National Cancer Institute's budget has actually declined since 2003.